home home Korean


Tego Science CEO Interview 관리자  |  2015.03.12

We are striving to elevate Tego Science to a position of global dominance in the field of cell therapy and tissue engineering. Since the IPO last November, we are accelerating our efforts to expand overseas. Previously a virtual unknown in the financial community, Tego is now an object of much interest to investors, domestic and overseas. We continue to engage in investor relations activities in Seoul, Hong Kong and Singapore. For details (in Korean), follow the link below.


url: http://www.edaily.co.kr/news/public/pop_print.asp?newsid=01315286609302664